What is TriSalus Life Sciences, Inc.'s Shariah compliance score?

TriSalus Life Sciences, Inc. (TLSI) has a Shariah compliance score of 56/100 (Grade: C+, Fair). AAOIFI Standard No. 21 requires: (1) no primary involvement in prohibited activities like alcohol, gambling, or conventional banking, (2) debt-to-market-cap below 30%, (3) interest-bearing deposits below 30%, and (4) prohibited income below 5%.

Does TriSalus Life Sciences, Inc. pass AAOIFI screening?

TriSalus Life Sciences, Inc. (TLSI) passes AAOIFI Shariah screening. AAOIFI Standard No. 21 requires: (1) no primary involvement in prohibited activities like alcohol, gambling, or conventional banking, (2) debt-to-market-cap below 30%, (3) interest-bearing deposits below 30%, and (4) prohibited income below 5%. TLSI's debt-to-market-cap is 16.3%.

How much purification is needed for TriSalus Life Sciences, Inc.?

Muslim investors purify the portion of dividends and realized gains that comes from non-permissible income by donating it to charity. HalalScreener's purification calculator at halalscreener.app/en/purification computes the percentage and amount for TriSalus Life Sciences, Inc. (TLSI) using the latest financial data.

Where can I screen TriSalus Life Sciences, Inc. for Shariah compliance for free?

HalalScreener (halalscreener.app) offers free Shariah compliance screening for TriSalus Life Sciences, Inc. (TLSI) and 8,200+ securities. US-listed stocks and ETFs are screened under AAOIFI Standard No. 21. Bursa Malaysia securities carry the Securities Commission Malaysia's official status. Coins are screened separately, under published scholarly opinion. The verdict is free, with no credit card or signup required for basic screening. The compliance grade, score, and debt ratio are free too; the full ratio breakdown is part of Pro.

TLSIHalalC+

Unlock full report, free

Is TriSalus Life Sciences (TLSI) Stock Halal?

Compliance Status

Halal

Screened on Nov 10, 2026 · AAOIFI Standard 21

C+

Fair

56Score

Is TriSalus Life Sciences, Inc. (TLSI) halal? Halal. Based on AAOIFI screening, TriSalus Life Sciences, Inc. passes both qualitative (business activity) and quantitative (financial ratio) screens with a compliance score of 56/100 (Grade: C+).

Quote this verdict

HalalScreener rates TriSalus Life Sciences, Inc. (TLSI) Halal, 56/100, grade C+ under AAOIFI Standard 21, screened Nov 10, 2026. Source: https://halalscreener.app/en/stock/TLSI

AvoidBorderlineClean

Business activity

What the company sells is permissible.

Passed

Company debt

Within the limit

How much the company borrows, compared to its total value. AAOIFI allows up to 30%.

16.3% of 30.0% limit

PRO DETAIL

The verdict above is final and free.

Pro members can verify every number behind it: interest-bearing deposits, prohibited income breakdown, and the full AAOIFI math.

Card needed, nothing charged today

Screened according to AAOIFI Standard 21

What this means for you

You can own TLSI

It passes both the business activity and financial ratio screens under AAOIFI Standard 21.

Purification amount is Pro

We have screened TLSI's prohibited income, but the exact share you would need to purify is part of Pro.

See plans

Share this verdict

A receipt-style image with the math on it, so whoever you send it to can check it.

TLSI

TriSalus Life Sciences, Inc.

NASDAQHealthcareUS

$2.30

Market Cap: 141.6M

Screened on a market cap of 198.3M

Get an email if TLSI's halal status changes

We re-screen TriSalus Life Sciences, Inc. daily. If the verdict moves, you hear about it the same day.

Free. One click sets it up, and you can unsubscribe any time.

About TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc. is an immunotherapy firm dedicated to the research, development, and market introduction of treatments that leverage the body's immune system, primarily targeting liver and pancreatic cancers. The company's product portfolio includes the TriNav Infusion System, designed for hepatic arterial infusion to treat liver tumors, and the Pancreatic Retrograde Venous Infusion System, which addresses pancreatic tumors. Additionally, TriSalus is advancing SD-101, an investigational immunotherapeutic that incorporates pressure-enabled drug delivery technology. This experimental therapy is currently being explored for its application in hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company's operations are headquartered in Westminster, Colorado.

Sector: Healthcare · Industry: Medical - Devices

Shariah Compliance Status

AAOIFI Standard 21Updated Nov 10, 2026

AI Compliance InsightProSee plans

Revenue BreakdownProSee plans

Compliance History

Halal, unchanged since Aug 2026.

No status changes recorded since we began tracking.

Tracked since Aug 2026. Updates automatically on each re-screen.

Fiscal: Q3 2026Data source: EDGAR

More Healthcare Stocks

JNJ

Johnson & Johnson

UNH

UnitedHealth Group Incorporated

ABBV

AbbVie Inc.

PFE

Pfizer Inc.

LLY

Eli Lilly and Company

A+

MRK

Merck & Co., Inc.

Free · No credit card required

Know the day TLSI's verdict changes

A free account keeps watch on 3 stocks and emails you when a verdict moves. You also get 3 questions for the AI Scholar. No card needed.

Get Started Free Browse Screener

8,200+ assets AAOIFI standards Free watchlist

Frequently Asked Questions

Is TriSalus Life Sciences, Inc. (TLSI) halal to invest in?

Based on AAOIFI Standard 21 screening, TriSalus Life Sciences, Inc. (TLSI) is rated Halal with a compliance grade of C+ (Fair). It passes both the business activity screen (no primary involvement in prohibited sectors) and the quantitative financial ratio screen (debt, interest deposits, and prohibited income all below AAOIFI thresholds).

Why did TriSalus Life Sciences, Inc. get a C+ compliance rating?

TriSalus Life Sciences, Inc. (TLSI) received a grade of C+ (Fair) based on three AAOIFI Standard 21 financial ratios: debt-to-market-cap of 16.3% (limit 30%); interest-bearing deposits within the 30% limit; prohibited income within the 5% limit. The grade reflects the margin of safety across all three ratios relative to their thresholds.

What could change TriSalus Life Sciences, Inc.'s Shariah verdict?

TriSalus Life Sciences, Inc.'s verdict is recalculated at every re-screen, including the one that follows each new quarterly or annual report. Three events could change it: (1) the debt-to-market-cap ratio crossing 30%, typically from new debt issuance or a major drop in share price; (2) interest-bearing deposits exceeding 30% of market cap; or (3) prohibited revenue (alcohol, gambling, conventional finance, etc.) exceeding 5% of total revenue. Verdict flips are tracked in the compliance history section above.

How often is TriSalus Life Sciences, Inc. re-screened for Shariah compliance?

TriSalus Life Sciences, Inc. (TLSI) is screened from the latest financial statements on record, currently those for fiscal Q3 2026. The 500 largest US-listed companies, and every stock on a HalalScreener watchlist or portfolio, are re-screened daily against the current market cap; every other stock at least once a week. When the company files a new quarterly or annual report with the SEC, it is re-screened from that filing: we check the SEC's filing feed every 15 minutes and the earnings calendar every day. Last screened: Nov 10, 2026.

Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.